Showing results (711-720 of 3,354) with videos related to
Sort By:
Pageof 336
Nature|March 19, 1987
HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cellsM Hooper, K Hardy, A Handyside, et al.The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 10, 2024
Medication Management Through Collaborative Practice for Children With Medical Complexity: A Prospective Case SeriesJena Quinn, Heather Monk Bodenstab, Emily Wo, et al.Journal of Fungi (Basel, Switzerland)|October 25, 2024
Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma aurisStephanie Toepfer, Mikhail V Keniya, Michaela Lackner, et al.Psychiatry Research|March 13, 2009
Replicable differences in preferred circadian phase between bipolar disorder patients and control individualsJoel Wood, Boris Birmaher, David Axelson, et al.European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|January 28, 2016
Changing the Management from Olecranon Screw Traction to Percutaneous Wiring for Displaced Supracondylar Fractures of the Humerus in Children. A Justified Decision?James R Lewis, John Monk, Amit P Chandratreya, et al.Psychological Science|August 22, 2003
Sleep deprivation influences some but not all processes of supervisory attentionJ R Jennings, T H Monk, M W van der MolenDrugs|October 1, 1988
Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertensionE Saltiel, A G Ellrodt, J P Monk, et al.Nature Neuroscience|September 8, 2020
Live-imaging of astrocyte morphogenesis and function in zebrafish neural circuitsJiakun Chen, Kira E Poskanzer, Marc R Freeman, et al.Development (Cambridge, England)|October 9, 2020
Perturbation analysis of a multi-morphogen Turing reaction-diffusion stripe patterning system reveals key regulatory interactionsAndrew D Economou, Nicholas A M Monk, Jeremy B A GreenInternational Journal of Chronic Obstructive Pulmonary Disease|December 10, 2020
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency RegistryFranck F Rahaghi, Richard Monk, Viswanathan Ramakrishnan, et al.Pageof 336